Advanced Cooling Therapy, a company out of Chicago, Illinois, won the European CE Mark approval for its Esophageal Cooling Device (ECD) used to control patient temperature from deep within the body. Fast and convenient cooling of patients suffering from a heart attack, as an example, can help prevent further damage to the brain and other organs.
The ECD device is similar to traditional gastric tubes, but has three lumens within. Two are used to pump a thermal liquid through the device, while the third provides suction for decompression and drainage.
From the announcement:
The ECD can be rapidly inserted by most trained health care professionals, in similar fashion to a standard gastric tube, and can be used to control patient temperature in the operating room, recovery room, emergency room, or ICU. No other product on the market is approved to use the esophageal environment for whole-body temperature modulation.
ACT’s President and Co-Founder, Erik Kulstad, MD, MS, said, “As an Emergency Room physician, I know intimately the challenges associated with traditional temperature management – bulky blankets, expensive machines, and invasive catheter procedures. The ECD is safe, easy to use, and cost-effective, and we look forward to commercialization in Europe with the CE marking.”
Product page: ECD Esophageal Cooling Device…
Press release: Emerging Medical Device Firm Advanced Cooling Therapy Receives European Union CE Mark for Its Novel Esophageal Cooling Device…